Results 1 to 10 of about 596 (171)

The influence of a peritoneovenous shunt for cirrhotic and malignant intractable ascites on renal function [PDF]

Acta Radiologica Open, 2018
Background Peritoneovenous shunts (PVS) are widely used for palliation of intractable ascites caused by peritoneal carcinomatosis (PC) or liver cirrhosis (LC). Some patients who need PVS have renal dysfunction.
Shigeru Ehara
exaly   +4 more sources

Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis [PDF]

Tomography
Background: Refractory ascites affects the prognosis and quality of life in patients with liver cirrhosis. Peritoneovenous shunt (PVS) is a treatment procedure of palliative interventional radiology for refractory ascites.
Shingo Koyama, Asako Nogami, Masato Yoneda, Shihyao Cheng, Yuya Koike, Yuka Takeuchi, Michihiro Iwaki, Takashi Kobayashi, Satoru Saito, Daisuke Utsunomiya, Atsushi Nakajima   +10 more
doaj   +3 more sources

Treatment of Refractory Chylous Ascites with an Innovative Peritoneovenous Shunt: Temporary Usage of a Continuous Renal Replacement System: A Case Report [PDF]

Journal of Chest Surgery, 2022
Esophagectomy and esophageal reconstruction are commonly chosen as surgical options for esophageal cancer. However, prolonged untreated chyle leakage is associated with a poor prognosis.
Jiyoun Park, Jae Jun Lee, Jung Hee Lee, Young Mog Shim   +3 more
doaj   +2 more sources

Transcatheter arterial embolization for postoperative hemorrhage complicating surgical repair of incarcerated umbilical hernia subsequent to Denver peritoneovenous shunting: A case report [PDF]

Radiology Case Reports, 2022
A 50-year-old man with a refractory ascites was inserted a peritoneovenous shunt under local anesthesia. On the fifth postoperative day, abdominal pain occurred and were diagnosed as incarcerated umbilical hernia.
Hiraku Funakoshi, MD, MPH, PhD, Shogo Shirane, MD, Masayoshi Yamamoto, MD, Eriko Yamaguchi, MD, Yasuaki Motomura, MD, PhD   +4 more
doaj   +2 more sources

Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation

Research and Practice in Thrombosis and Haemostasis, 2021
Peritoneovenous shunts (PVSs) are used to relieve ascites in cirrhosis. Disseminated intervascular coagulation (DIC) is a complication of PVSs requiring immediate PVS removal.
Fabienne Lucas, Michael S. Stecker, Olga Pozdnyakova, Jean M. Connors, Elisabeth M. Battinelli   +4 more
doaj   +2 more sources

Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites [PDF]

World Journal of Surgical Oncology, 2011
Purpose To evaluate a new modified peritoneovenous shunt therapy, the externalized peritoneovenous shunt (EPVS) system placement, used to treat patients with malignant ascites.
Sakamoto Noriaki, Sofue Keitaro, Arai Yasuaki, Takeuchi Yoshito, Tokue Hiroyuki, Tsushima Yoshito, Endo Keigo   +6 more
doaj   +2 more sources

Long-term results of peritoneovenous shunt implantation for refractory ascites in patients with alcoholic liver cirrhosis: single-center retrospective study of 348 patients [PDF]

BMJ Surgery, Interventions, & Health Technologies
Introduction Despite its reasonable pathophysiological basis, peritoneovenous shunt (PVS) implantation currently plays a very limited role in managing patients with refractory ascites. On the other hand, we have 20 years of experience using PVSs. The aim
Krisztina Fekete, Péter Kupcsulik
doaj   +2 more sources

Postoperative chylous ascites after total gastrectomy successfully treated using peritoneovenous (Denver) shunt: a case report [PDF]

Surgical Case Reports, 2022
Background Chylous ascites (CA) is a rare complication of gastrectomy for gastric cancer. While most cases of postoperative CA improve with medication or nutritional support, some are refractory to conservative treatment.
Shinya Sakamoto, Nobuo Takata, Yoshihiro Noda, Kazuhide Ozaki, Takehiro Okabayashi   +4 more
doaj   +2 more sources

TIPS to Treat Chylous Ascites due to Cirrhosis. [PDF]

Clin Case Rep
ABSTRACT Chylous ascites is a rare form of ascites that arises from the disruption of lymphatic flow. It develops in patients with liver cirrhosis secondary to portal hypertension. Treatment options include dietary modifications, pharmacological agents, and procedural interventions.
Amir M, Farooq AU, Zahid R, Farooq M, Akilimali A.   +4 more
europepmc   +2 more sources

Successful treatment of chylous leakage with delayed presentation after endometrial cancer surgery using dietary therapy, octreotide, and computed tomography-guided lymphangiography: A case report and literature review. [PDF]

J Obstet Gynaecol Res
Abstract Objective Chylous ascites (CA) is a rare yet clinically significant complication following gynecologic cancer surgery, with incidence rates of 0.17 % to 9%. We aimed to describe a case of CA with a delayed clinical presentation nearly 100 days postoperatively in a patient with advanced endometrial cancer and to review the management strategies.
Takahashi T, Kisu I, Kiyokawa S, Anko M, Ohno H, Okamura T, Hirao N.   +6 more
europepmc   +2 more sources